Skip to main contentrtttttt Skip to main content
Integrative Psychiatry

An Ecotherapy Approach to Climate Grief

By March 19, 2024No Comments

Psychological wellbeing is deeply tied to the environment. Connections to the natural world and relationships with the wilderness inside of us are seeds for the development of meaning, purpose, and spirituality. Humans evolved to coexist with the ecosystems of the planet, although the exploitation of land and marginalized peoples has helped distort this view across centuries. Ecotherapy is a therapeutic modality that explores the interconnectedness of the individual with all beings, both human and nonhuman. Approached through a social justice framework, ecotherapy can highlight the sociopolitical contexts that underlie the current climate and mental health crises. 

Climate grief, defined as a profound sense of loss, sadness, and anxiety in response to climate change, is a growing concern in the mental health field. It might be argued that presentations of many kinds of existential concerns (i.e., isolation, meaning, freedom, and death) are intimately rooted within societal impacts of the climate crisis. Understanding the tenets of ecopsychology can provide valuable insights into the underlying causes of mental health issues that may be exacerbated by environmental crises. For example, integrating ecotherapy principles into clinical practice can support clients’ exploration of personal experiences of existential anxieties related to climate grief and the broader socio-ecological contexts in which they occur. Recognizing the intersections of social, environmental, and psychological factors can support a more inclusive and intersectional approach to assessment and treatment.

Ecotherapy and related perspectives (such as ecofeminism) consider social ecosystems to be living organisms that require nourishment through meeting diverse needs. Thus, ecotherapy challenges the ideologies of superiority, domination, and separateness. This model assumes that people, as all living creatures, operate in cyclical and nonlinear phases. Marginalization of self, others, and the environment might arise from structures of colonialism that place value on control and subjugation of parts, people, and nonhuman beings. By embodying the fluidity of natural physiological and psychological rhythms, ecotherapy approaches are poised to support cultural liberation.

Environmental degradation disproportionately impacts marginalized communities (one example of this is represented through the microbiome; read more here). A social justice lens of ecotherapy recognizes how environmental degradation and social injustices intersect, perpetuating cycles of oppression and ecological harm. Addressing structural inequalities that contribute to environmental injustices can affirm experiences and lay a foundation for empowerment and resilience. 

One of the key insights of ecotherapy is the recognition of the interrelatedness of all life forms and the inherent value of non-human beings. By challenging anthropocentric perspectives that prioritize human interests above those of other species, ecotherapeutic perspectives invite us to consider the ethical implications of our actions on the planet and its inhabitants. This perspective can be particularly relevant in the context of climate grief, as individuals may experience feelings of guilt, helplessness, or despair in response to ecological destruction. Clients may be supported by fostering a sense of belonging within the natural world, helping to mitigate feelings of alienation. Relationships with nature can also instill personal empowerment and sense of control, contributing to agency in the development of individual or collective purpose.

Ecopsychology orientations to therapy contemplate physiological, mental-emotional, and spiritual impacts of environmental crises. The integration of ecotherapy principles into clinical practice may help holistically address climate-related distress through an environmental and social justice approach.

Sara Reed, MS, LMFT

Sara Reed is a Licensed Marriage and Family Therapist and CEO of Mind’s iHealth Solutions, a digital health company that provides evidence based and culturally responsible mental health services for underserved groups. As a mental health futurist and clinical researcher, Sara examines the ways culture informs the way we diagnose and treat mental illness. Sara’s prior research work includes participation as a study therapist in psychedelic therapy research at Yale University and the University of Connecticut’s Health Center. Sara was the first Black therapist to provide MDMA-assisted psychotherapy in a clinical trial and continues to engage in ongoing advocacy work around health equity in psychedelic medicine.

https://psychiatryinstitute.com/wp-content/uploads/2019/11/Jeffrey-Guss.png

Jeffrey Guss, MD is a psychiatrist, psychoanalyst, and researcher with specializations in psychoanalytic therapy and the treatment of substance use disorders. He was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicine’s study on psychedelic-assisted psychotherapy in the treatment of cancer-related existential distress, which was published in Journal of Psychopharmacology, 2016. He currently is a study therapist in the NYU study on Psychedelic-Assisted therapy in the treatment of Alcoholism, a collaborator with Yale University’s study on psychedelic-assisted therapy for Major Depressive Disorder and a study therapist with the MAPS (Multidisciplinary Association for Psychedelic Studies) study on treatment of Post Traumatic Stress Disorder with Psychedelic-Assisted Psychotherapy. 

Dr. Guss is interested in the integration of psychedelic therapies with contemporary psychoanalytic theory and has published in Studies in Gender and Sexuality and Psychoanalysis, Culture and Society. He has published (with Elizabeth Nielson, PhD) a paper on “the influence of therapists’ first had experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training” in The Journal of Psychedelic Studies, August, 2018. He is an Instructor and Mentor with the California Institute of Integral Studies’ Center for Psychedelic Therapies and Supervisor in NYU’s Fellowship in Addiction Psychiatry. 

Dr. Guss maintains a private practice in New York City.

Will Van Derveer, MD

Will Van Derveer, MD is Co-Founder of Integrative Psychiatry Institute and Integrative Psychiatry Centers. Dr. Van Derveer was co-investigator on a phase 2 MAPS study of Psychedelic-assisted psychotherapy for treatment-resistant PTSD, and co-authored the publication of this study in 2018. He has also provided Psychedelic-assisted psychotherapy in two MAPS training studies. An active provider of KAP at his clinic in Boulder, CO, he has been teaching others KAP therapy for several years. Dr. Van Derveer contributed a chapter on mescaline in the 2021 "Handbook of Medical Hallucinogens" (edited by Charles Grob and Jim Grigsby). He is co-host of the Higher Practice Podcast.

Dr. Van Derveer regards unresolved emotional trauma as the most significant under-recognized root cause of psychiatric symptoms in integrative psychiatry practice, along with gut issues, hormone imbalances, inflammation, mitochondrial dysfunction, and other functional medicine challenges. He is trained in Somatic Experiencing, EMDR, Internal Family Systems, and other psychotherapy techniques. His current clinical passion is psychedelic-assisted psychotherapy, which he mentors interested doctors in providing. An avid meditator, he has been a meditation instructor since 2004.

For the past several years Dr. Van Derveer has taught psychiatrists and other psychiatric providers integrative psychiatry in a number of settings, including course directing the CU psychiatry residents’ course as well as with Scott Shannon and Janet Settle at the Psychiatry MasterClass.


Scott has been a student of consciousness since his honors thesis on that topic at the University of Arizona in the 1970s under the tutelage of Dr. Andrew Weil. Following medical school, Scott studied Jungian therapy and acupuncture while working as a primary care physician in a rural area for four years. Psychedelic-assisted psychotherapy became a facet of his practice before this medicine was scheduled in 1985. He then completed a psychiatry residency at Columbia program in New York. Scott studied cross-cultural psychiatry and completed a child/adolescent psychiatry fellowship at the University of New Mexico.

In 2010 he founded Wholeness Center in Fort Collins. This innovative clinic provides cross-disciplinary evaluation and care for all mental health concerns. Scott serves as a site Principal Investigator and therapist for the Phase III trial of psychedelic-assisted psychotherapy for PTSD sponsored by (MAPS). He has also published numerous articles about his research on (CBD) in mental health. Currently, Scott works extensively with psychedelic-assisted-psychotherapy. He lectures all over the world to professional groups interested in a deeper look at mental health issues, safer tools, and a paradigm-shifting perspective about transformative care.

Will Van Derveer, MD is co-founder of Integrative Psychiatry Institute (IPI), along with friend and colleague Keith Kurlander, MA. He co-created IPI as an expression of what he stands for. First, that anyone can heal, and second that we medical providers must embrace our own healing journeys in order to fully command our potency as healers.

Dr. Van Derveer spent the last 20 years innovating and testing a comprehensive approach to addressing psychiatric challenges which transcends the conventional model he learned in medical school at Vanderbilt University and residency at University of Colorado, while deeply engaging his own healing path.

He founded the Integrative Psychiatric Healing Center in in 2001 in Boulder, CO, where he currently practices. Dr. Van Derveer regards unresolved emotional trauma as the most significant root cause of psychiatric symptoms in integrative psychiatry practice, along with gut issues, hormone imbalances, inflammation, mitochondrial dysfunction, and other functional medicine challenges. He is trained in Somatic Experiencing, EMDR, Internal Family Systems, and other psychotherapy techniques. His current clinical passion is psychedelic-assisted psychotherapy, which he mentors interested doctors in providing. An avid meditator, he has been a meditation instructor since 2004.

For the past several years Dr. Van Derveer has taught psychiatrists and other psychiatric providers integrative psychiatry in a number of settings, including course directing the CU psychiatry residents’ course as well as with Scott Shannon and Janet Settle at the Psychiatry MasterClass. In addition to his clinical work and teaching, he was co-investigator in 2016 a Phase II randomized clinical trial, sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS). He continues to support this protocol, now in a Phase III clinical trial under break-through designation by FDA.

Dr. Van Derveer is a diplomate of the American Board of Integrative and Holistic Medicine (ABoIHM) since 2013, and he was board certified in the first wave of diplomates of the new American Board of Integrative Medicine (ABIM) in 2016.